Ryvu Therapeutics SA – Trademark Portfolio
Entity Type: 09
Ryvu Therapeutics SA holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RYVU and RYVU THERAPEUTICS.
ul. Bobrzynskiego 14
Showing of trademarks Trademarks
Trademark Classifications
Ryvu Therapeutics SA's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Ryvu Therapeutics SA have?
Ryvu Therapeutics SA has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Ryvu Therapeutics SA file in?
Ryvu Therapeutics SA files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Ryvu Therapeutics SA's most well-known trademarks?
Ryvu Therapeutics SA's registered trademark portfolio includes well-known marks such as RYVU and RYVU THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.
What is Ryvu Therapeutics SA's trademark registration success rate?
Ryvu Therapeutics SA has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.